Fully Owned Sites. Centralized Operations.
If you've worked with research site networks, you know that it's about more than access. When every networked site is directly owned and operated, you get alignment.
MBR coordinates contracting, budgets, startup, regulatory support, participant recruitment, data support, and quality oversight through one centralized operating infrastructure.
For you, that means clear accountability and a more consistent study experience from award through closeout.
Speed and Control
MBR is built to compress startup timelines without cutting corners.
Centralized teams support faster budget and contract turnaround, coordinated regulatory submissions, and parallel startup activity when appropriate.
The result is a more efficient path to activation, first participant in, and study conducted thereafter.
Simplicity for Your Complex Trials
Complex trials need sites that can handle the operational weight.
MBR supports demanding study designs across the network, including serial sampling, infusion, diagnostics, combination product research, intensive visit schedules, and early-phase protocols.
The Monroe campus adds dedicated overnight and Phase 1 capabilities, while Louisville and Charleston bring specialty depth in metabolic and respiratory research.
Recruitment as a Core Operational Function
Enrollment is often an afterthought for sites. A last-mile tactic that's often outsourced.
MBR is invested in directly engaging participants — outreach teams, active participant databases, community engagement, and prescreening workflows are embedded into site operations.
That structure helps your trial reach the right participants faster, support retention, and improve representation with greater intention.
A Happier Experience for Participants
MBR is built around the idea that participant experience is operationally important.
Comfortable facilities, responsive communication, engaged site teams, and trust-based recruitment help reduce avoidable friction throughout the study.
For your researfch program, that can mean stronger retention, better visit compliance, and smoother day-to-day execution.
Full Alignment With Your Team and Your Research Program
For Large Pharma and CROs
You need scalable site execution without unnecessary variability.
MBR gives your study team one coordinated partner across fully owned sites, aligned processes, therapeutic depth, recruitment infrastructure, and purpose-built facilities for both specialty and general medicine programs.
For Startups/Biotechs
Lean teams need site partners that can anticipate what comes next. That's MBR.
MBR provides experienced site leadership, startup support, recruitment readiness, and operational coordination that help your team move with confidence from feasibility through closeout.
Built to Uphold a Higher Standard
Our Sites
Every MBR site is directly owned, staffed, and operated. That means shared infrastructure, aligned teams, consistent standards, and greater control across your trial.
-
Charleston, SC
Monroe Biomedical Research, 4975 Lacross Road, Suite 200-B, North Charleston, SC 29406MBR Charleston is a respiratory-focused clinical research site with strong internal medicine capabilities, specialized staff, and rapid startup support. -
Louisville, KY
Monroe Biomedical Research, 3288 Illinois Avenue, Louisville, KY 40213MBR’s Louisville site is a prolific metabolic research facility with Phase 1–4 capabilities and strong central operational support. -
Monroe, NC (East Building)
Monroe Biomedical Research, 343 Venus St, Monroe, NC 28112MBR’s Monroe East Building is a dedicated overnight and early-phase research facility with Phase 1 infrastructure, serial sampling support, and 24-hour operational coverage. -
Monroe, NC (West Building)
Monroe Biomedical Research, 343 Venus St, Monroe, NC 28112MBR’s Monroe West Building is a high-efficiency outpatient clinical research site supported by Monroe campus infrastructure, quality systems, and recruitment resources.
Featured Investigators
MBR's principal investigators are clinically engaged physicians with research experience, therapeutic depth, and established participant relationships.
-
Awawu E. Igbinadolor, MD
Dr. Awawu E. Igbinadolor is a highly accomplished Principal Investigator with broad experience across internal medicine clinical trials. At Monroe Biomedical Research, she has led studies across respiratory disease, diabetes, hypertension, Alzheimer’s disease, and COVID-19 research. She has completed more than 100 trials across diverse therapeutic areas and is experienced with first-in-human, dose-escalation, SAD/MAD, crossover, and adaptive designs in early Phase 1 trials. Dr. Igbinadolor is a strong fit for general medicine trials, with deep experience in cardiometabolic, endocrine, respiratory, infectious disease, vaccine, and early-phase studies. -
Claire Presswood, MD
Claire Presswood, MD, is a board-certified Internal Medicine physician, Diplomate of the American Board of Obesity Medicine, and Principal Investigator with years of clinical trial experience. She has been an investigator on over 100 clinical trials, with research interests in obesity, diabetes, post-bariatric hypoglycemia, hypertension, hyperlipidemia, cardiovascular outcomes, MASH, vaccines, devices, healthy participant studies, and Phase 1-3 clinical trials. -
Gregory Feldman, MD, CPI
Gregory Feldman, MD, is a triple-board-certified physician in Internal Medicine, Critical Care, and Pulmonology, with more than 30 years of experience working with pulmonary patients in clinical trials. Since 2007, he has completed more than 200 studies, with particular depth in respiratory, vaccine, and cardiometabolic research. He leads MBR Charleston as Principal Investigator and is a standout respiratory and pulmonology investigator. -
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC, has served as Principal Investigator for more than 700 clinical trials of metabolic therapeutic interventions and is one of the strongest scientific differentiators across the MBR network. Hae was Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center, Inc. (L-MARC), which was acquired by MBR in 2025. He is a nationally recognized investigator for obesity, endocrinology, lipid disorders, cardiometabolic disease, and MASH/MASLD research. -
Keith Horvath, MD
Keith Horvath, MD, is an investigator with Monroe Biomedical Research in North Charleston, South Carolina. A board-certified surgeon with specialty training in cardiothoracic surgery, Dr. Horvath has decades of experience in cardiac and thoracic care, academic medicine, and clinical research. He earned his medical degree from the University of Chicago Pritzker School of Medicine and completed surgical training at Brigham and Women’s Hospital, with additional research training at Massachusetts General Hospital. His research background spans cardiovascular surgery, valve disease, CABG, atrial fibrillation, transfusion practices, renal protection, neuroprotection, and cardiac surgery outcomes. At MBR, he supports clinical research with a strong foundation in surgical expertise, patient care, and evidence-based medicine. -
Rasheed Onafuye, MD
Dr. Rasheed Onafuye is a psychiatrist and clinical researcher with extensive experience caring for adults with complex mental health, sleep, and metabolic conditions. At Monroe Biomedical Research, he serves as Principal Investigator and Sub-Investigator for trials. He is a key investigator for psychiatry, sleep medicine, addiction, CNS, and controlled-substance studies, and also supports obesity and chronic weight management research.
New at MBR
-
MBR Welcomes Felicia Irvin as Chief Commercial Officer
We’re welcoming Felicia Irvin to MBR as Chief Commercial Officer. Felicia brings more than 15 years of experience in clinical research, with expertise spanning business development, operations, patient recruitment, and network growth. She has built her career by bridging commercial commitments with operational delivery. As CCO, she will lead MBR’s … Read more
-
Monroe Biomedical Research Acquires L-MARC to Expand Therapeutic Expertise and Geographic Footprint
Monroe Biomedical Research (MBR), a leading clinical trial site network specializing in patient recruitment for complex clinical trials, has completed the acquisition of L-MARC (Louisville Metabolic and Atherosclerosis Research Center, Inc.), a nationally recognized clinical research site based in Louisville, Kentucky. Founded by Dr. Harold Bays, L-MARC has built a strong reputation … Read more
-
Understanding and Managing Agitation in Alzheimer’s
Agitation in Alzheimer’s can signal discomfort, confusion, fear, pain, or an unmet need. Learn common triggers and practical caregiver strategies.